ACCORD-Lipid trial, postprandial lipaemia and cardiovascular risk: outcomes a current interpretation

Abstract

Recent randomized clinical trials have shown evidence of benefit and safety of more intensive LDL cholesterol lowering in patients with atherogenic dyslipidaemia and established cardiovascular disease supporting guidelines for a more intensive LDL goal of therapy.

Keywords

• triglyceride metabolism
• fibrates